Wearable Health Solutions (WHSI) 10-Q 18 Feb 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Sep. 30, 2021	Feb. 15, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--06-30
Entity File Number	333-153290
Entity Registrant Name	WEARABLE HEALTH SOLUTIONS, INC.
Entity Central Index Key	0001443089
Entity Tax Identification Number	26-3534190
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2300 Yonge St.
Entity Address, Address Line Two	Suite 1600
Entity Address, Address Line Three	Ontario M4P
Entity Address, City or Town	Toronto
Entity Address, State or Province	NV
Entity Address, Country	CA
Entity Address, Postal Zip Code	1E4
City Area Code	855
Local Phone Number	226 4827
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,080,492,608

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Current Assets
Cash and cash equivalents	$ 1,752,795	$ 847,430
Accounts receivable, net	0	25,694
Accounts receivable, other	2,000	2,000
Prepaid Inventory	0	22,682
Prepaid expenses	59,600	10,000
Total Current Assets	1,814,395	907,806
Property, Plant & Equipment
Dealer portal (net of $849 and $0 depreciation)	49,151	0
Property, Plant & Equipment	49,151	0
Total Assets	1,863,546	907,806
LIABILITIES and SHAREHOLDERS' DEFICIT
COMMITMENTS AND CONTINGENCIES (Note 12)
Current liabilities
Accounts payable	300,491	331,876
Accrued expenses and other current liabilities	312,540	296,920
Accrued expenses - related party	609,378	579,673
Deferred revenue	106,756	108,298
Line of credit	397,500	397,500
Derivative liability	343,200	281,845
Notes payable	554,776	853,244
Note payable – other	50,000	50,000
Note payable - related party	425,000	425,000
Convertible notes – Leonite	180,000	260,000
Convertible notes- other	673,750	673,750
Total current liabilities	3,953,391	4,258,106
TOTAL LIABILITIES	3,953,391	4,258,106
Common stock
Common Stock: $0.0001 par value; 3,000,000,000 shares authorized, 911,843,430 and 647,074,177 shares issued and outstanding as of September 30, 2021 and June 30, 2021, respectively	91,184	64,708
Common stock to be issued (15,275,000 and 20,050,000 shares as of September 30, 2021 and June 30, 2021, respectively)	131,503	169,005
Additional paid in capital	28,358,311	22,732,295
Accumulated deficit	(30,728,961)	(26,374,227)
Total Shareholders’ Deficit	(2,089,845)	(3,350,300)
Total Liabilities and Shareholders’ Deficit	1,863,546	907,806
Series A Preferred Stock [Member]
Preferred stock
Preferred stock	1	1
Series B Preferred Stock [Member]
Preferred stock
Preferred stock	1	1
Series C Preferred Stock [Member]
Preferred stock
Preferred stock	684	684
Series D Preferred Stock [Member]
Preferred stock
Preferred stock	43	43
Series E Preferred Stock [Member]
Preferred stock
Preferred stock	390	190
Preferred stock to be issued	$ 57,000	$ 57,000

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
[custom:AccumulatedDepreciationDepletionPortalAndAmortizationPropertyPlantAndEquipment-0]	$ 849	$ 0
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	14,000,000
Preferred Stock to be issued	100,000	100,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	911,843,430	647,074,177
Common stock, shares outstanding	911,843,430	647,074,177
Common stock to be issued	15,275,000	20,050,000
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	688	688
Preferred stock, shares outstanding	688	688
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	62,500	62,500
Preferred stock, shares issued	9,938	9,938
Preferred stock, shares outstanding	9,938	9,938
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	6,944,445	6,944,445
Preferred stock, shares issued	6,838,889	138,886
Preferred stock, shares outstanding	6,838,889	138,886
Series D Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	425,000	425,000
Preferred stock, shares outstanding	425,000	425,000
Series E Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	3,900,000	1,900,000
Preferred stock, shares outstanding	3,900,000	1,900,000

Consolidated Statement of Profi

Consolidated Statement of Profit and Loss (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 302,872	$ 362,653
Cost of sales	(203,511)	(159,870)
Gross profit	99,361	202,783
Operating expenses
Selling expense	148,079	3,556
Research and development expense	149,000
Depreciation expense	849	0
Consulting and professional fees	172,454	141,635
Insurance	15,917	10,290
Rent	4,455	3,718
Salaries and wages	3,529,453	1,955,164
Software expense	93,477	3,597
General and administrative	82,784	30,649
Total operating expenses	4,196,468	2,148,609
Loss from operations	(4,097,107)	(1,945,826)
Other (Income) / expense
Change in fair value of derivative instrument	238,155
Gain on debt extinguishment	(15,832)
Interest expense	35,304	3,766
Total other expenses	257,627	3,766
Net loss before taxes	(4,354,735)	(1,949,592)
Income tax	0	0
Net loss	$ (4,354,735)	$ (1,949,592)
Net loss per common share - Basic and Diluted	$ (0.02)	$ (0.02)
Weighted average common shares outstanding - Basic & Diluted	195,378,542	96,330,751

Consolidated Statement of Share

Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series B [Member]	Preferred Stock Series C [Member]	Series C To Be Issued [Member]	Preferred Stock Series D [Member]	Preferred Stock Series E [Member]	Series E To Be Issued [Member]	Common Stock [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
As at June 30, 2021 at Jun. 30, 2020	$ 1	$ 1	$ 14	$ 375,200	$ 43	$ 400	$ 650,000	$ 29,740	$ 71,415	$ 18,578,122	$ (3,356,285)
Beginning balance, shares at Jun. 30, 2020	688	9,938	138,886	6,700,003	425,000	4,000,000	1,000,000	297,399,177	10,350,000
Loss for the period											(1,949,592)	(1,949,592)
Issuance of Series C Preferred shares			$ 670	$ (375,200)						374,530
Issuance of Series C Preferred shares, shares			6,700,003	(6,700,003)
Return of preferred stock						$ (400)					(400)
Return of preferred stock, shares						(4,000,000)
Preferred stock issued/officer comp						$ 100	(80,000)			649,900	570,000
Preferred stock issued/officer comp, shares						1,000,000
Common stock issued/officer comp								$ 20,000	$ 1,500	1,120,000	1,141,500
Common stock issued/officer comp, shares								200,000,000	150,000
As at September 30, 2021 at Sep. 30, 2020	$ 1	$ 1	$ 684		$ 43	$ 100	$ 570,000	$ 49,740	$ 72,915	20,722,552	(3,594,777)	(3,350,300)
Ending balance, shares at Sep. 30, 2020	688	9,938	6,838,889		425,000	1,000,000	1,000,000	497,399,177	10,500,000
As at June 30, 2021 at Jun. 30, 2021	$ 1	$ 1	$ 684		$ 43	$ 190	$ 57,000	$ 64,708	$ 169,005	22,732,295	(3,350,301)	(3,350,300)
Beginning balance, shares at Jun. 30, 2021	688	9,938	6,838,889		425,000	1,900,000	100,000	647,074,177	20,050,000
Loss for the period											(4,354,735)	(4,354,735)
Common stock for comp								$ 700	$ 60,000	74,300	135,000
Common stock for comp, shares								7,000,000	5,000,000
Common stock for debt conversion								$ 2,527		250,166	252,693
Common stock for debt conversion, shares								25,269,253
Common stock for officer comp									$ 2,498		2,498
Common stock for officer comp, shares									225,000
Preferred stock for compensation						$ 200				2,999,800	3,000,000
Preferred stock for compensation, shares						2,000,000
Shares sold for cash								$ 23,250	$ (100,000)	2,301,750	2,225,000
Shares sold for cash, shares								232,500,000	(10,000,000)
As at September 30, 2021 at Sep. 30, 2021	$ 1	$ 1	$ 684		$ 43	$ 390	$ 57,000	$ 91,184	$ 131,503	$ 28,358,311	$ (2,089,845)	$ (2,089,845)
Ending balance, shares at Sep. 30, 2021	688	9,938	6,838,889		425,000	3,900,000	100,000	911,843,430	15,275,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flow from operating activities
Net loss	$ (4,354,735)	$ (1,949,592)
Adjustment for non cash charges and other items:
Depreciation	849	0
Common stock issued for services	0	(500,000)
Stock compensation expense	3,137,498	2,373,920
Change in fair value of derivative instrument	238,155	173,406
Gain on debt extinguishment	(15,832)	0
Total	(994,066)	97,734
Changes in working capital
Decrease / (increase) in accounts receivables	25,694	18,847
Decrease / (increase) in prepaid inventory	22,682	(137,478)
Decrease / (increase) in prepaid expenses	(49,600)	38,195
(Decrease) / increase in trade and other payables	(31,385)	15,381
(Decrease) / increase in accrued expenses	27,344	47,362
(Decrease) / increase in deferred revenue	(1,542)	(257)
Total	(6,806)	(17,950)
Cash flow used in operating activities	(1,000,872)	79,784
Cash flow provided by investing activities
Purchases of property and equipment	(50,000)	0
(Decrease) / increase in notes payable	0	(701,542)
Cash flow from investing activities	(50,000)	(701,542)
Cash flow provided by financing activities
Proceeds from issuance of stock for cash	2,225,000	0
Advances from related party	29,705	121,758
Proceeds from note payable	20,000	500,000
Repayments of note payable	(318,468)	0
Cash flow from financing activities	1,956,237	621,758
Increase in cash and cash equivalents	905,365	0
Cash and cash equivalents at beginning of the year	847,430	701,542
Cash and cash equivalents at end of the year	1,752,795	701,542
Non-cash investing and financing activities
Write off of derivative liability due to debt conversion	176,800	0
Issuance of common stock for conversion of notes payable and conversion fees	7,225	0
Interest	0	0
Taxes	$ 0	$ 0

Nature and Continuance of Opera

Nature and Continuance of Operations	3 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature and Continuance of Operations	Note 1 – Nature and Continuance of Operations Wearable Healthcare Solutions Inc. (the Company) was incorporated as Medical Alarm Concepts Holding, Inc. on June 4, 2008, under the laws of the State of Nevada. The Company was formed for the sole purpose of acquiring all of the membership units of Medical Alarm Concepts LLC, a Pennsylvania limited liability company (“Medical LLC”). On May 26, 2016, the Company filed an Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to change its name from “Medical Alarm Concepts, Inc.” to “Wearable Health Solutions Inc.” The Company is primarily engaged in utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical or age-related conditions. Basis of presentation The accompanying interim condensed consolidated financial statements are unaudited, but in the opinion of management of Wearable Healthcare Solutions, Inc. (the Company), contain all adjustments, which include normal recurring adjustments, necessary to present fairly the financial position at September 30, 2021 and the results of operations and cash flows for the three months ended September 30, 2021. The balance sheet as of June 30, 2021, is derived from the Company’s audited financial statements. Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although management of the Company believes that the disclosures contained in these financial statements are adequate to make the information presented therein not misleading. For further information, refer to the financial statements and the notes thereto included in the Company’s Annual Report on this Form 10 for the fiscal year ended June 30, 2021. The results of operations for the three months ended September 30, 2021, are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2022.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Basis of Presentation Principles of Consolidation Use of Estimates Cash and Cash Equivalents Accounts Receivable 0 25,694 23,705 23,705 Software Development for internal use 50,000 5 Concentration of Credit Risk Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical- or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues when the service is provided. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues and records the balance of revenues as they become current. Schedule of deferred revenues 3 months ended September 30, 2021 2020 REVENUES Hardware revenue $ 53,583 $ 129,241 Service revenue 249,289 233,412 TOTAL REVENUES $ 302,872 $ 362,653 The following table discloses changes in unearned revenue for the three months ended September 30, 2021 and 2020: Schedule of unearned revenue 2021 2020 Balance at beginning of period - June 30, $ 108,298 $ 174,107 Deferred revenue 2,682 3,025 Recognition of unearned revenue (4,224 ) (3,025 ) Balance at the end of the period - September 30, $ 106,756 $ 174,107 Deferral of revenues in the three months ended September 30, 2021 and 2020 was $ 105,756 174,107 Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2021, 2020, and 2019 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed. Fair value of financial instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards. Research and Development 149,000 0 Basic and Diluted Loss per Common Share - Schedule of antidilutive shares Basis of conversion Dilution 2021 2020 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 and 138,886 shares outstanding in 2021 and 2020, respectively 1 share C: 10 shares 68,388,890 1,388,860 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 3,900,000 and 4,000,000 shares outstanding in 2021 and 2020, respectively 1 share E: 100 shares 390,000,000 400,000,000 Series E Convertible Shares to be issued 100,000 and 1,000,000 Series E shares to be issued in 2021 and 2020, respectively 1 share E: 100 shares 10,000,000 100,000,000 472,660,142 505,660,112 Because the Company incurred losses for the past two years, the basic and diluted share bases will be presented as the same. For the periods ended September 30, 2021 and 2020, the Company incurred losses of ($0.02) and ($0.02) per basic share and diluted share, respectively. Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes the current accounting for leases and while retaining two distinct types of leases, finance and operating, (1) requires lessees to record a right of use asset and a related liability for the rights and obligations associated with a lease, regardless of lease classification, and recognize lease expense in a manner similar to current accounting, (2) eliminates most real estate specific lease provisions, and (3) aligns many of the underlying lessor model principles with those in the new revenue standard. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. For public companies, the new standard is effective for annual and interim periods in fiscal years beginning after December 15, 2018. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December 15, 2019, and interim periods within fiscal years beginning after December 2020. Earlier application is permitted. The Company evaluated the impact on the financial statements and implemented the provisions of ASU 2016-02 for the annual financial statements for the year ended June 30, 2019. In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity in accounting standards. The amendments in the ASU are effective for fiscal years beginning after December 15, 2020, including interim periods therein. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. The Company is currently evaluating the effect, if any, that the ASU will have on its consolidated financial statements. The Company reviewed all recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC, and they did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Going Concern

Going Concern	3 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 – Going Concern The accompanying financial statements for the three months ended September 30, 2021 and 2020 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As at September 30, 2021 and June 30, 2021, the Company has shown losses for the last 2 years and has an accumulated deficit of ($ 30,728,961 26,374,227 These factors raise substantial doubt about our ability to continue as a going concern for a period of 12 months from the issue date of this report. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Inventory and prepaid expenses

Inventory and prepaid expenses	3 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Inventory and prepaid expenses	Note 4 – Inventory and prepaid expenses The Company maintains some inventories in house and purchases some of its inventory overseas. Inventories, except for stock in transit, are stated at lower of cost and net realizable value. Stock in transit is valued at cost comprising invoice value plus other charges thereon. Net realizable value is the estimated selling price in ordinary course of business less estimated costs of completion and selling expenses. The quantity of inventory may vary from time to time depending on the delivery schedule of overseas shipments. As of September 30, 2021 and June 30, 2021, the Company had $- 0 0 0 22,682 The Company recorded prepaid public relations and investor relations (PR/IR) services of $ 21,600 10,000 20,000 18,000 As of September 30, 2021 and June 30, 2021, the Company had $ 59,600 10,000

Property, Plant, and Equipment

Property, Plant, and Equipment	3 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment	Note 5 - Property, Plant, and Equipment The Company has $20,000 in furnishings, $19,689 in office computers and equipment, and capitalized software development costs of $45,900 which are fully depreciated. On August 30, 2021, the Company purchased its dealer portal for $50,000 for internal use, amortized over 60 months. As of September 30, 2021 and June 30, 2021, the Company recorded $ 49,151 0 Schedule of property, plant and equipment September 2021 June 2021 Furniture $ 20,000 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer Portal 50,000 – Property, plant, and equipment 135,589 85,589 Less accumulated depreciation – portal (849 ) – Less accumulated depreciation (85,589 ) (85,589 ) Net property, plant, and equipment $ 49,151 $ –

Accounts payable and accrued ex

Accounts payable and accrued expenses and liabilities	3 Months Ended
	Sep. 30, 2021
Payables and Accruals [Abstract]
Accounts payable and accrued expenses and liabilities	Note 6 – Accounts payable and accrued expenses and liabilities The Company recorded Accounts Payable of $ 300,491 331,876 Accrued expenses are expenses that have been incurred but not yet paid, mainly include legal fees, audit fees and other professional fees as well as interests accrued in connection with credit line. The Company recorded $ 312,540 296,920 3(a)(10) filing On August 17, 2020, the Wearable Health Solutions, Inc., (the “Company”) entered into a settlement agreement and stipulation (“Settlement Agreement”) with Trillium Partners LP (“Trillium”) in connection with the settlement of $ 310,494 In October 2020, the company issued 48,989,000 60 48,989,000

Notes Payable and Note payable-

Notes Payable and Note payable-other	3 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Notes Payable and Note payable-other	Note 7 – Notes Payable and Note payable-other Notes payable consists of notes payable from our subsidiary, notes payable-other, convertible notes payable, notes payable for stock purchases under Reg A, short term notes payable, and notes payable-BOAPIN portal, as follows: Schedule of notes payable September 30, 2021 June 30, 2021 Notes from subsidiary $ 219,775 $ 238,244 Short term bridge loan 200,000 500,000 Note payable- Reg A deposits 135,000 115,000 Total Notes Payable $ 554,775 $ 853,244 Notes Payable - subsidiary The Company has various loans and credit lines outstanding. The credit line carries an interest rate of 6.24%. The bank loans carry interest rates varying between 9.24% – 10.90%. Schedule of loans outstanding September 30, 2021 June 30, 2021 Wells Fargo Loan $ 11,482 $ 12,454 On Deck Loan 139,569 139,569 Susquehanna Salt Loan 42,000 52,500 Prosper Loans 13,303 17,771 MARCUS Loan 13,421 15,949 TOTAL LOANS $ 219,775 $ 238,244 Debt settlement – On Deck, Susquehanna, MCA Cure In 2019, our subsidiary engaged MCA CURE to negotiate settlements with On Deck and Susquehanna Salt. The Company ceased paying the loan payments and paid MCA Cure $ 43,875 47,000 33,705 18,705 The Company impaired the MCA Cure amounts paid, and of September 30, 2021 and June 30, 2021, the Company recorded $ 139,569 42,000 52,500 Short term bridge loan - COHEN On July 31, 2020, the Company secured a $ 500,000 12 12 At September 30, 2020, the Company recorded short-term note payable of $ 500,000 10,027 At June 30, 2021, the Company recorded short term note payable of $ 500,000 55,047 On August 19, 2021, the Company repaid $ 300,000 200,000 12 200,000 10,981 Note payable – stock purchases under Reg A In March 2021 and June 2021, the Company accepted loans of $ 115,000 20,000 5 At September 30, 2021 and June 30, 2021, the Company recorded $ 135,000 115,000 2,615 1,594 As of September 30, 2021 and June 30, 2021, the Company has outstanding $ 554,776 853,244 Note Payable – Other In November, 2016, the Company secured a $ 50,000 4 1,000,000 4 As of September 30, 2021 and June 30, 2021, the Company expensed $ 500 2,000 9,783 9,283 Convertible note payable – BENZA, D2CF On March 1, 2016 and March 3, 2016, the Company closed a private placement and received an aggregate of $ 612,500 660,000 13,750 61,250 76,250 673,750 As of September 30, 2021 and June 30, 2021, the Company reported $ 673,750 673,750 On July 22, 2021, the Company filed suit for damages resulting from the related party. On November 4, 2021, Benza Pharma LLC filed a countersuit. To date, there has been no resolution or settlement. The loans are recognized on the financials with no discount. Convertible Note: Leonite Capital, LLC On November 19, 2019, the Company, together with Hypersoft Ventures (collectively, the “Borrower”), received $ 135,000 150,000 15,000 250,000 77,778 0.02 2,700,000 260,000 The Company has determined that the conversion feature embedded in the Leonite Convertible Note constitutes a derivative and has been bifurcated from the Leonite Convertible Note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt, on the accompanying balance sheet, and revalued to fair market value at each reporting period. The initial issuance yielded a derivative liability of $ 94,225 150,000 Significant assumptions used in calculating fair value of conversion feature of Leonite Convertible Note at issuance date are as follows. Schedule of fair value of conversion feature Expected Expected Risk-free Expected Exercise Common stock 0.00 809.71 0.0154 0.75 $ 0.02 $ 0.01300 At June 30, 2020, the Company recorded $ 270,842 150,000 145,833 4,167 On June 4, 2021, the Company and Leonite renegotiated the convertible note for two years, face value of $ 260,000 524,561 11,003 260,000 2,285 On July 29, 2021, Leonite converted $ 42,750 2,250 15,000,000 44,475 2,250 10,269,253 15,832 Schedule of extinguishment of debt Balance at June 30, 2021 $ 260,000 Accrued interest 7,225 Leonite Convertible Note converted (87,225 ) Total 180,000 Less: debt discount – Balance at September 30, 2021 $ 180,000 The resulting derivative valuation is calculated as follows: Schedule of derivative liabilities at fair value Derivative as of June 30, 2021 $ 281,845 Change in fair value 238,155 520,000 Write off due to conversions (176,800 ) Derivative value as of September 30, 2021 $ 343,200 Significant assumptions used in calculating fair value of conversion feature of Leonite Convertible Note as of September 30, 2021 are as follows. Schedule of fair value of conversion features Expected Expected Risk-free Expected term Exercise Common stock 0.00 269.75 0.0007 1.9288 $ 0.00550 $ 0.01 In October 2021, Leonite converted the balance of the loan, conversion fees, and accrued interest, and extinguished the debt. Credit line – MediPendant New York Inc. On September 30, 2014, our subsidiary entered into a line of credit with Medi Pendant New York, Inc. (“MNY”), which is partially owned by a principal of its subsidiary. Under the line of credit agreement, the Company will be able to borrow up to $ 500,000 6.5 September 30, 2017 500,000 200,000 28,000 As of September 30, 2021 and June 30, 2021, the Company has recorded $ 397,500 397,500

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	3 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Stockholders’ Equity (Deficit)	Note 10 – Stockholders’ Equity (Deficit) Capital Stock The Company is currently authorized to issue 3,000,000,000 0.0001 14,000,000 0.0001 For the three months ended September 30, 2020, the Company issued 200,000,000 1,140,000 150,000 1,500 For the three months ended September 30, 2021, the Company issued 7,000,000 75,000 .0107 5,000,000 52,500 As of September 30, 2021 and June 30, 2021, the Company has 911,843,430 and 697,074,177 shares of common stock issued and outstanding, respectively. Offering pursuant to Regulation A On September 11, 2020, the Company filed a 1-A offering statement with the Securities and Exchange commission, offering up to 500,000,000 at $.01 to raise up to $5,000,000. The offering was amended on October 14, 2020, and can be viewed on the SEC website. Preferred Stock Series A Convertible Preferred Stock 100,000 0.0001 Series B Convertible Preferred Stock 62,500 0.0001 Series C Convertible Preferred Stock 6,944,445 0.0001 Series D Convertible Preferred Stock: The Company is currently authorized to issue, 500,000 0.0001 Series E Convertible Preferred Stock: The Company is currently authorized to issue 4,000,000 0.0001 During the three months ended September 30, 2020, the Company issued 6,700,003 375,000 .056 4,000,000 400 .0001 1,000,000 650,000 .65 During the three months ended September 30, 2021, the Company issued 1,000,000 3,000,000 1.50 As of September 30, 2021 and June 30, 2021, the Company had 688 9,938 6,838,889 425,000 3,900,000 All shares were valued at the stock price on the day of transaction or conversion.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 11 – Related Party Transactions Note payable – BOAPIN purchase In August 2020, effective as of June 30, 2020, the Company purchased the BOAPIN portal, including all software, licensing, and ownership rights from Hypersoft Ventures, Inc. for $425,670, which includes six million seven hundred thousand (6,700,003) shares of Series C Convertible Preferred stock and a note for $425,000, bearing twelve percent (12%) interest with no prepayment or delinquency clauses. As of September 30, 2021 and June 30, 2021, the Company has recorded Note payable-BOAPIN of $ 425,000 425,000 8,579 28,225 Accrued expenses and due to related party From time to time, related parties loaned the company working capital for day-to-day operations, respectively. These are short-term loans which bear no interest, and the Company expects to repay these loans within the coming year. In addition, salary accruals owed to the officers of the Company have been included in the Due to related party line item. As of September 30, 2021 and June 30, 2021, the Company owes $ 609,378 579,673

Commitments and contingencies

Commitments and contingencies	3 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Note 12 – Commitments and contingencies Commitments and Contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

Office lease

Office lease	3 Months Ended
	Sep. 30, 2021
Office Lease
Office lease	Note 13 - Office lease The Company maintains its corporate offices in Toronto on a month-to-month basis. The subsidiary maintains a warehouse office in Pennsylvania to facilitate inventory arrival and product shipment. The 3 year lease at $1,100 per month expired on September 30, 2021. The lease has been renewed for 12 months at $1,300 per month beginning October 1, 2021. Expenditures for the three months ending September 30, 2021 and 2020 are as follows: Schedule lease cost 2021 2020 Rent expense $ 3,300 $ 3,300

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 14 – Subsequent Events On October 7, 2021, Leonite Capital was issued a total of 13,231,209 common shares of the Company’s stock under the terms of their Note Payable for converting $57,952 of principle and interest plus fees of $2,250. On October 14, 2021, Leonite Capital was issued a total of 5,000,000 common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On October 27, 2021, Leonite Capital was issued a total of 27,917,969 common shares of the Company’s stock under the terms of their Note Payable for converting $124,776.76 principle plus fees of $2,250 to extinguish the note. On November 10, 2021, Leonite Capital was issued a total of 7,500,000 common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On November 12, 2021, East Capital., was issued a total of 10,000,000, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On November 15, 2021, Leonite Capital., was issued a total of 10,000,000, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On November 15, 2021, Apollo Management Group., was issued a total of 20,000,000, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On November 15, 2021, Bellridge Capital., was issued a total of 10,000,000, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On November 15, 2021, Eagle Equities., was issued a total of 15,000,000, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On November 17, 2021, Gail Rosenthal was issued a total of 10,000,000, common shares of the Company’s stock under the terms of the bonus contractor agreement before she accepted employment, The shares were valued at $69,000 or $0.0069, the value of the stock on the date of award. On November 22, 2021, Longside Ventures., was issued a total of 10,000,000, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. On January 6, 2022, Leonite Capital was issued a total of 20,000,000, common shares of the Company’s stock under the terms of the Regulation A offering which became qualified on November 12, 2020, The shares were issued under the terms of subscription agreements at the contracted price of $.01, in exchange for a total of $200,000, cash payments. Convertible note payable - LEONITE In October 2021, Leonite converted $182,729 and $4,450 in fees to 41,149,178 shares of common stock, and extinguished the debt. Note payable – related party - BOAPIN On October 28, 2021, the Company repaid $105,000 in principle.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
Principles of Consolidation	Principles of Consolidation
Use of Estimates	Use of Estimates
Cash and Cash Equivalents	Cash and Cash Equivalents
Accounts Receivable	Accounts Receivable 0 25,694 23,705 23,705
Software Development for internal use	Software Development for internal use 50,000 5
Concentration of Credit Risk	Concentration of Credit Risk
Recognition of Revenues	Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical- or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues when the service is provided. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues and records the balance of revenues as they become current. Schedule of deferred revenues 3 months ended September 30, 2021 2020 REVENUES Hardware revenue $ 53,583 $ 129,241 Service revenue 249,289 233,412 TOTAL REVENUES $ 302,872 $ 362,653 The following table discloses changes in unearned revenue for the three months ended September 30, 2021 and 2020: Schedule of unearned revenue 2021 2020 Balance at beginning of period - June 30, $ 108,298 $ 174,107 Deferred revenue 2,682 3,025 Recognition of unearned revenue (4,224 ) (3,025 ) Balance at the end of the period - September 30, $ 106,756 $ 174,107 Deferral of revenues in the three months ended September 30, 2021 and 2020 was $ 105,756 174,107
Deferred Taxes	Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2021, 2020, and 2019 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed.
Fair value of financial instruments	Fair value of financial instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards.
Research and Development	Research and Development 149,000 0
Basic and Diluted Loss per Common Share	Basic and Diluted Loss per Common Share - Schedule of antidilutive shares Basis of conversion Dilution 2021 2020 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 and 138,886 shares outstanding in 2021 and 2020, respectively 1 share C: 10 shares 68,388,890 1,388,860 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 3,900,000 and 4,000,000 shares outstanding in 2021 and 2020, respectively 1 share E: 100 shares 390,000,000 400,000,000 Series E Convertible Shares to be issued 100,000 and 1,000,000 Series E shares to be issued in 2021 and 2020, respectively 1 share E: 100 shares 10,000,000 100,000,000 472,660,142 505,660,112 Because the Company incurred losses for the past two years, the basic and diluted share bases will be presented as the same. For the periods ended September 30, 2021 and 2020, the Company incurred losses of ($0.02) and ($0.02) per basic share and diluted share, respectively.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes the current accounting for leases and while retaining two distinct types of leases, finance and operating, (1) requires lessees to record a right of use asset and a related liability for the rights and obligations associated with a lease, regardless of lease classification, and recognize lease expense in a manner similar to current accounting, (2) eliminates most real estate specific lease provisions, and (3) aligns many of the underlying lessor model principles with those in the new revenue standard. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. For public companies, the new standard is effective for annual and interim periods in fiscal years beginning after December 15, 2018. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December 15, 2019, and interim periods within fiscal years beginning after December 2020. Earlier application is permitted. The Company evaluated the impact on the financial statements and implemented the provisions of ASU 2016-02 for the annual financial statements for the year ended June 30, 2019. In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity in accounting standards. The amendments in the ASU are effective for fiscal years beginning after December 15, 2020, including interim periods therein. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. The Company is currently evaluating the effect, if any, that the ASU will have on its consolidated financial statements. The Company reviewed all recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC, and they did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Schedule of deferred revenues	Schedule of deferred revenues 3 months ended September 30, 2021 2020 REVENUES Hardware revenue $ 53,583 $ 129,241 Service revenue 249,289 233,412 TOTAL REVENUES $ 302,872 $ 362,653
Schedule of unearned revenue	Schedule of unearned revenue 2021 2020 Balance at beginning of period - June 30, $ 108,298 $ 174,107 Deferred revenue 2,682 3,025 Recognition of unearned revenue (4,224 ) (3,025 ) Balance at the end of the period - September 30, $ 106,756 $ 174,107
Schedule of antidilutive shares	Schedule of antidilutive shares Basis of conversion Dilution 2021 2020 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 and 138,886 shares outstanding in 2021 and 2020, respectively 1 share C: 10 shares 68,388,890 1,388,860 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 3,900,000 and 4,000,000 shares outstanding in 2021 and 2020, respectively 1 share E: 100 shares 390,000,000 400,000,000 Series E Convertible Shares to be issued 100,000 and 1,000,000 Series E shares to be issued in 2021 and 2020, respectively 1 share E: 100 shares 10,000,000 100,000,000 472,660,142 505,660,112

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	3 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Schedule of property, plant and equipment	Schedule of property, plant and equipment September 2021 June 2021 Furniture $ 20,000 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer Portal 50,000 – Property, plant, and equipment 135,589 85,589 Less accumulated depreciation – portal (849 ) – Less accumulated depreciation (85,589 ) (85,589 ) Net property, plant, and equipment $ 49,151 $ –

Notes Payable and Note payabl_2

Notes Payable and Note payable-other (Tables)	3 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Schedule of notes payable	Schedule of notes payable September 30, 2021 June 30, 2021 Notes from subsidiary $ 219,775 $ 238,244 Short term bridge loan 200,000 500,000 Note payable- Reg A deposits 135,000 115,000 Total Notes Payable $ 554,775 $ 853,244
Schedule of loans outstanding	Schedule of loans outstanding September 30, 2021 June 30, 2021 Wells Fargo Loan $ 11,482 $ 12,454 On Deck Loan 139,569 139,569 Susquehanna Salt Loan 42,000 52,500 Prosper Loans 13,303 17,771 MARCUS Loan 13,421 15,949 TOTAL LOANS $ 219,775 $ 238,244
Schedule of fair value of conversion feature	Schedule of fair value of conversion feature Expected Expected Risk-free Expected Exercise Common stock 0.00 809.71 0.0154 0.75 $ 0.02 $ 0.01300
Schedule of extinguishment of debt	Schedule of extinguishment of debt Balance at June 30, 2021 $ 260,000 Accrued interest 7,225 Leonite Convertible Note converted (87,225 ) Total 180,000 Less: debt discount – Balance at September 30, 2021 $ 180,000
Schedule of derivative liabilities at fair value	Schedule of derivative liabilities at fair value Derivative as of June 30, 2021 $ 281,845 Change in fair value 238,155 520,000 Write off due to conversions (176,800 ) Derivative value as of September 30, 2021 $ 343,200
Schedule of fair value of conversion features	Schedule of fair value of conversion features Expected Expected Risk-free Expected term Exercise Common stock 0.00 269.75 0.0007 1.9288 $ 0.00550 $ 0.01

Office lease (Tables)

Office lease (Tables)	3 Months Ended
	Sep. 30, 2021
Office Lease
Schedule lease cost	Schedule lease cost 2021 2020 Rent expense $ 3,300 $ 3,300

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Product Information [Line Items]
Revenues	$ 302,872	$ 362,653
Hardware Revenue [Member]
Product Information [Line Items]
Revenues	53,583	129,241
Service Revenue [Member]
Product Information [Line Items]
Revenues	$ 249,289	$ 233,412

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1) - Deferred Revenue [Member] - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Regulatory Liabilities [Line Items]
Deferred revenue, Beginning	$ 108,298	$ 174,107
Deferred revenue	2,682	3,025
Recognition of unearned revenue	(4,224)	(3,025)
Deferred revenue, Ending	$ 106,756	$ 174,107

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details 2) - shares	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
AntiDilutive Shares	472,660,142	505,660,112
Series A Preferred Stock [Member]
AntiDilutive Shares	1,376	1,376
Series B Preferred Stock [Member]
AntiDilutive Shares	19,876	19,876
Series C Preferred Stock [Member]
AntiDilutive Shares	68,388,890	1,388,860
Series D Preferred Stock [Member]
AntiDilutive Shares	4,250,000	4,250,000
Series E Preferred Stock [Member]
AntiDilutive Shares	390,000,000	400,000,000
Series E Preferred Stock To Be Issued [Member]
AntiDilutive Shares	10,000,000	100,000,000
Series A Convertible Stock [Member]
Basis of conversion	688 shares outstanding
Dilution	1 share A: 2 shares
Series B Convertible Stock [Member]
Basis of conversion	9,938 shares outstanding
Dilution	1 share B: 2 shares
Series C Convertible Stock [Member]
Basis of conversion	6,838,889 and 138,886 shares outstanding in 2021 and 2020, respectively
Dilution	1 share C: 10 shares
Series D Convertible Stock [Member]
Basis of conversion	425,000 shares outstanding
Dilution	1 share D: 10 shares
Series E Convertible Stock [Member]
Basis of conversion	3,900,000 and 4,000,000 shares outstanding in 2021 and 2020, respectively
Dilution	1 share E: 100 shares
Series E Convertible Shares To Be Issued [Member]
Basis of conversion	100,000 and 1,000,000 Series E shares to be issued in 2021 and 2020, respectively
Dilution	1 share E: 100 shares

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Aug. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021
Accounts receivable, net		$ 0		$ 25,694
Allowance for doubtful accounts		23,705		$ 23,705
Purchase of dealer portal	$ 50,000
Depreciated years	5 years
Deferred revenue		105,756	$ 174,107
Research and development costs		149,000
Research and Development Expense [Member]
Research and development costs		$ 149,000	$ 0

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 30,728,961	$ 26,374,227

Inventory and prepaid expenses

Inventory and prepaid expenses (Details Narrative) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Inventory, net	$ 0	$ 0
Prepaid inventories	0	22,682
Prepaid inventory	59,600	10,000
Research and Development Expense [Member]
Prepaid investmet		18,000
Bankings [Member]
Prepaid investmet	20,000
Investee [Member]
Prepaid inventories	$ 21,600	$ 10,000

Property, plant and equipment (

Property, plant and equipment (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 135,589	$ 85,589
Accumulated depreciation	(849)	0
Accumulated depreciation	(85,589)	(85,589)
Property, plant and equipment, net	49,151	0
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	20,000	20,000
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	19,689	19,689
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	45,900	45,900
Dealer Portal [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 50,000

Property, Plant, and Equipmen_2

Property, Plant, and Equipment (Details Narrative) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Other, Net	$ 49,151	$ 0

Accounts payable and accrued _2

Accounts payable and accrued expenses and liabilities (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021
Defined Benefit Plan Disclosure [Line Items]
Accounts payable	$ 300,491	$ 331,876
Accrued liabilities	312,540	$ 296,920
Trillium Partners L P [Member]
Defined Benefit Plan Disclosure [Line Items]
Company owed to certain of creditors	310,494
W H S I [Member]
Defined Benefit Plan Disclosure [Line Items]
Common stock issued	$ 48,989,000
Common stock percentage price	60.00%
Treasury shares returned	$ 48,989,000

Notes Payable and Note Payable

Notes Payable and Note Payable - Other (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Debt Disclosure [Abstract]
Notes from subsidiary	$ 219,775	$ 238,244
Short term bridge loan	200,000	500,000
Note payable- Reg A deposits	135,000	115,000
Total Notes Payable	$ 554,775	$ 853,244

Notes Payable and Note Payabl_3

Notes Payable and Note Payable - Other (Details 1) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Debt Instrument [Line Items]
Notes payable	$ 219,775	$ 238,244
Wells Fargo [Member]
Debt Instrument [Line Items]
Notes payable	11,482	12,454
On Deck Loan [Member]
Debt Instrument [Line Items]
Notes payable	139,569	139,569
Susquehanna Salt Loan [Member]
Debt Instrument [Line Items]
Notes payable	42,000	52,500
Prosper [Member]
Debt Instrument [Line Items]
Notes payable	13,303	17,771
Marcus [Member]
Debt Instrument [Line Items]
Notes payable	$ 13,421	$ 15,949

Notes Payable and Note Payabl_4

Notes Payable and Note Payable - Other (Details 2) - Leonite [Member]	3 Months Ended
	Sep. 30, 2021$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Expected Dividends	0.00%
Expected volatility	809.71%
Risk-free rate of interest	0.0154%
Expected term (year)	9 months
Exercise conversion price	$ 0.02
Common stock price per share	$ 0.01300

Notes Payable and Note Payabl_5

Notes Payable and Note Payable - Other (Details 3)	3 Months Ended
	Sep. 30, 2021USD ($)
Debt Instrument [Line Items]
Convertible debt, beginning balance	$ 180,000
Convertible debt, ending balance	180,000
Leonite Capital [Member]
Debt Instrument [Line Items]
Convertible debt, beginning balance	260,000
Convertible debt issued	7,225
Convertible debt converted	(87,225)
Convertible debt, beginning balance	180,000
Debt discount
Convertible debt, ending balance	$ 180,000

Notes Payable and Note Payabl_6

Notes Payable and Note Payable - Other (Details 4)	3 Months Ended
	Sep. 30, 2021USD ($)
Debt Disclosure [Abstract]
Derivative liabilities, Beginning	$ 281,845
Change in fair value	238,155
Total Fair Value Derivative Liabilities	520,000
Write off due to conversions	(176,800)
Derivative liabilities, Ending	$ 343,200

Notes Payable and Note Payabl_7

Notes Payable and Note Payable - Other (Details 5) - Leonite 1 [Member]	3 Months Ended
	Sep. 30, 2021$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Expected Dividends	0.00%
Expected Volatility	269.75%
Risk-free rate of interest	0.0007%
Expected term (year)	1 year 11 months 4 days
Exercise conversion price	$ 0.00550
Common stock price per share	$ 0.01

Notes Payable and Note payabl_8

Notes Payable and Note payable-other (Details Narrative) - USD ($)	Jun. 04, 2021	Aug. 19, 2021	Jul. 31, 2021	Jul. 29, 2021	Jul. 31, 2020	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2019
Short-term Debt [Line Items]
Short term bridge loan						$ 200,000	$ 500,000		$ 500,000
Short term notes payable						200,000		$ 500,000		$ 500,000
Interest and accrued interest liability						10,981		10,027	55,047
Principle amount repaid		$ 300,000
Accrued interest		$ 200,000
Accrued Interest		12.00%
Notes payable for stock purchases						135,000	115,000		115,000
Notes payable, other						2,615	1,594		1,594
Notes payable						554,776	853,244		853,244
Notes payable related parties						$ 425,000	425,000		425,000
Interest rate						4.00%
Interest fees						$ 500	2,000
Accrued interest payable						9,783	9,283
Convertible notes payable						180,000
Derivative Liability, Current						343,200	281,845		281,845
Gain (Loss) on Extinguishment of Debt						$ 15,832		0
Maturity date						Sep. 30, 2017
Increased amount						$ 500,000
Issuance of shares value						0		500,000
Line of credit balance						397,500	397,500		397,500
Medi Pendant New York Inc [Member]
Short-term Debt [Line Items]
Borrowed amount						$ 500,000
Rate of interest						6.50%
Issuance of shares						200,000
Issuance of shares value						$ 28,000
Leonite [Member]
Short-term Debt [Line Items]
issuance yielded a derivative liability						94,225
Issuance of discount						150,000
Derivative liabilities										270,842
Derivative liabilities										150,000
Convertible notes payable										145,833
Penalties and default fees										$ 4,167
Convertible note face value	$ 260,000
Derivative Liability, Current	524,561
Loss on valuation	11,003
Debt discount	260,000
Accrued interest	$ 2,285
Debt Instrument, Convertible, Liquidation Preference, Value				$ 42,750		44,475
Debt Instrument, Fee Amount				$ 2,250		$ 2,250
Debt Conversion, Converted Instrument, Shares Issued				15,000,000		10,269,253
Hypersoft Ventures [Member]
Short-term Debt [Line Items]
Company recieved amount						$ 135,000
Hypersoft Ventures [Member] | Leonite [Member]
Short-term Debt [Line Items]
Issued discount						77,778
Unsecured convertible note						$ 250,000
Anti dilution shares						$ 0.02
Shares purchased						2,700,000
Interest and penalities						$ 260,000
Hypersoft Ventures [Member] | Unitranche Debt [Member]
Short-term Debt [Line Items]
Company recieved amount						150,000
Issued discount						15,000
Private Placement [Member]
Short-term Debt [Line Items]
Aggregate amount						612,500
Original issue discount						61,250
Amortization of debt discount						76,250
Loan balance due						673,750
Convertible notes payable						$ 673,750	673,750		673,750
Chief Executive Officer [Member]
Short-term Debt [Line Items]
Interest rate						4.00%
Notes payable related parties						$ 50,000
Acquisition of convertible notes payable						1,000,000
Two Unaffiliated Investors [Member]
Short-term Debt [Line Items]
Loans accepted			$ 20,000				115,000		115,000
Notes payable interest rate			5.00%
B E N Z A [Member] | Private Placement [Member]
Short-term Debt [Line Items]
Unsecured convertible notes						660,000
B 2 C F [Member] | Private Placement [Member]
Short-term Debt [Line Items]
Unsecured convertible notes						13,750
M C A Cure [Member]
Short-term Debt [Line Items]
Loan payments								47,000			$ 43,875
Cash at bank								$ 18,705			$ 33,705
Amounts paid						139,569
Susquehanna [Member]
Short-term Debt [Line Items]
Amounts paid						$ 42,000	$ 52,500		$ 52,500
C O H E N [Member]
Short-term Debt [Line Items]
Short term bridge loan					$ 500,000
Interest rate					12.00%
Accrue interest					12.00%

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021
Class of Stock [Line Items]
Common stock, shares authorized	3,000,000,000		3,000,000,000
Common stock, par value	$ 0.0001		$ 0.0001
Preferred stock, shares authorized	14,000,000
Preferred stock, par value	$ 0.0001
Stock issued for services, value	$ 0	$ 500,000
Shares issued	7,000,000
Contractual bonuses	$ 75,000
Contractual bonus price per share	$ 0.0107
Accured shares	5,000,000
Bonus paid amount	$ 52,500
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	100,000		100,000
Preferred stock, par value	$ 0.0001		$ 0.0001
Preferred stock, shares issued	688		688
Preferred stock, shares outstanding	688		688
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	62,500		62,500
Preferred stock, par value	$ 0.0001		$ 0.0001
Preferred stock, shares issued	9,938		9,938
Preferred stock, shares outstanding	9,938		9,938
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	6,944,445		6,944,445
Preferred stock, par value	$ 0.0001		$ 0.0001
Shares issued		6,700,003
Issued amount		$ 375,000
Issued price		$ 0.056
Preferred stock, shares issued	6,838,889		138,886
Preferred stock, shares outstanding	6,838,889		138,886
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	500,000		500,000
Preferred stock, par value	$ 0.0001		$ 0.0001
Preferred stock, shares issued	425,000		425,000
Preferred stock, shares outstanding	425,000		425,000
Series E Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	4,000,000		4,000,000
Preferred stock, par value	$ 0.0001		$ 0.0001
Shares issued	1,000,000	4,000,000
Issued amount	$ 3,000,000	$ 400
Issued price	$ 1.50	$ 0.0001
Preferred stock, shares issued	3,900,000		1,900,000
Preferred stock, shares outstanding	3,900,000		1,900,000
Series E Preferred Stock [Member] | Two Officer [Member]
Class of Stock [Line Items]
Shares issued		1,000,000
Issued amount		$ 650,000
Issued price		$ 0.65
New Owner [Member]
Class of Stock [Line Items]
Stock issued for services, shares		200,000,000
Stock issued for services, value	$ 1,140,000
Accrued, shares	150,000
Accrued, value	$ 1,500

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Sep. 30, 2021	Jun. 30, 2021
Related Party Transaction [Line Items]
Note payable	$ 180,000
Accrued interest	8,579	$ 28,225
Related party payables	609,378	579,673
Boapin [Member]
Related Party Transaction [Line Items]
Note payable	$ 425,000	$ 425,000

Office lease (Details)

Office lease (Details) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Office Lease
Rent expense	$ 3,300	$ 3,300